Hepatitis C Clinical Trials 2023
Browse 67 Hepatitis C Medical Studies Across 120 Cities
5 Phase 3 Trial · 246 Hepatitis C Clinics
Reviewed by Michael Gill, B. Sc.
10 Hepatitis C Clinical Trials Near Me
Top Hospitals for Hepatitis C Clinical Trials
Johns Hopkins University
Baltimore
5Active Trials
18All Time Trials for Hepatitis C
2002First Hepatitis C Trial
Denver Health Medical Center
Denver
2Active Trials
2All Time Trials for Hepatitis C
2019First Hepatitis C Trial
University of Kentucky
Lexington
2Active Trials
4All Time Trials for Hepatitis C
2018First Hepatitis C Trial
Top Cities for Hepatitis C Clinical Trials
Hepatitis C Clinical Trials by Phase of TrialN/A Hepatitis C Clinical Trials
Hepatitis C Clinical Trials by Age Group29Active Hepatitis C Clinical Trials
29Number of Unique Treatments
30Number of Active Locations
18 - 65 Hepatitis C Clinical Trials
Most Recent Hepatitis C Clinical Trials5Active Hepatitis C Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
Treatment Name
Active Hepatitis C Clinical Trials
All Time Trials for Hepatitis C
First Recorded Hepatitis C Trial
Treatment
5
5
2003
sofosbuvir/velpatasvir
3
5
2017
Epclusa
3
9
2016
Glecaprevir/pibrentasvir
2
6
2016
Point of Care (POC) HCV Viremia (RNA) testing
1
1
2022
Treatment
Year
Sponsor
glecaprevir/pibrentasvir (GLE/PIB)
2021
University of California, San Diego
Epclusa (SOF/VEL)
2020
University of California, San Francisco
Ribavirin (RBV)
2019
AIDS Clinical Trials Group
Epclusa
2019
Pablo Sanchez
glecaprevir/pibrentasvir treatment
2019
Raymond Chung
Zepatier
2018
University of Pennsylvania
Elbasvir / Grazoprevir Oral Tablet [Zepatier]
2018
University of Maryland, Baltimore
Sofosbuvir/Velpatasvir
2018
Elizabeth Krans, MD
Harvoni
2017
Wake Forest University Health Sciences
About The Author
Michael Gill - B. Sc.
First Published: October 17th, 2021
Last Reviewed: September 13th, 2023
References1 Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Gonçales FL Jr, Häussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 2002 Sep 26;347(13):975-82. https://pubmed.ncbi.nlm.nih.gov/123245532 Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL Jr, Haussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 2002 Sep 26;347(13):975-82. doi: 10.1056/NEJMoa020047. https://pubmed.ncbi.nlm.nih.gov/123245533 Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet. 2001 Sep 22;358(9286):958-65. https://pubmed.ncbi.nlm.nih.gov/115837494 Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet. 2001 Sep 22;358(9286):958-65. doi: 10.1016/s0140-6736(01)06102-5. https://pubmed.ncbi.nlm.nih.gov/115837495 Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001 Jul 5;345(1):41-52. doi: 10.1056/NEJM200107053450107. No abstract available. https://pubmed.ncbi.nlm.nih.gov/114399486 Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001 Jul 5;345(1):41-52. Review. https://pubmed.ncbi.nlm.nih.gov/114399487 Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006 May 16;144(10):705-14. https://pubmed.ncbi.nlm.nih.gov/167025868 Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006 May 16;144(10):705-14. doi: 10.7326/0003-4819-144-10-200605160-00004. https://pubmed.ncbi.nlm.nih.gov/167025869 Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999 Aug 19;341(8):556-62. https://pubmed.ncbi.nlm.nih.gov/1045146010 Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999 Aug 19;341(8):556-62. doi: 10.1056/NEJM199908193410802. https://pubmed.ncbi.nlm.nih.gov/10451460